Peringkat dalam Saham
#29054
PT Indofarma Tbk, along with its affiliated entities, is dedicated to the... PT Indofarma Tbk, along with its affiliated entities, is dedicated to the production and marketing of pharmaceutical goods across Indonesia. The company's activities encompass the commerce and supply of a diverse range of items, including medications, medical equipment, healthcare provisions, various extracts, and herbal products. It also operates its own laboratory facilities and provides specific COVID-19 diagnostic services, such as rapid antigen testing, reverse transcription polymerase chain reaction (RT-PCR), and Genose tests. Additionally, the firm engages in the export of its merchandise. Established in 1918, Indofarma Tbk maintains its primary operations in Bekasi, Indonesia. Historically, the company was known as PT Indofarma (Persero) Tbk and now functions as a subsidiary of PT. Bio Farma.
Harga Saham
$0.00748841
Terakhir disinkronkan: 2024-07-01
Kapitalisasi Pasar
$23.21M
Perubahan (1 hari)
-2.83%
Perubahan (1 tahun)
0.00%
Perdagangan PT Indofarma Tbk (INAF)
Harga INAF dengan kapitalisasi pasar B
Kapitalisasi pasar dari PT Indofarma Tbk(INAF)
Kapitalisasi Pasar: $23.21M
Per August 2026, PT Indofarma Tbk memiliki kapitalisasi pasar sebesar $23.21M. Ini menjadikan PT Indofarma Tbk sebagai perusahaan 29054th paling bernilai di dunia menurut data kami. Kapitalisasi pasar adalah nilai total saham beredar dari perusahaan publik dan biasanya digunakan untuk mengukur seberapa besar nilai sebuah perusahaan.
Riwayat kapitalisasi pasar PT Indofarma Tbk dari 2001 hingga 2026
INAF dibandingkan dengan 5 teratas stocks paling populer
| Harga INAF |
|
Aset B |
Pasar B |
Hasil |
|
|
|
|
$5.310T
|
+22,879,229.90%
|
|
|
|
|
$4.645T
|
+20,012,243.33%
|
|
|
|
|
$4.166T
|
+17,949,420.71%
|
|
|
|
|
$3.609T
|
+15,548,430.23%
|
|
|
|
|
$2.847T
|
+12,266,798.43%
|
